Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 745043, 4 pages
http://dx.doi.org/10.1155/2015/745043
Review Article

Precision Medicine for Continuing Phenotype Expansion of Human Genetic Diseases

Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, NAB 2015, Houston, TX 77030, USA

Received 11 March 2015; Accepted 12 May 2015

Academic Editor: Peter Nicholas Robinson

Copyright © 2015 Hui Yu and Victor Wei Zhang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Yang, D. M. Muzny, J. G. Reid et al., “Clinical whole-exome sequencing for the diagnosis of mendelian disorders,” The New England Journal of Medicine, vol. 369, no. 16, pp. 1502–1511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Tang, J. Wang, N.-C. Lee et al., “Mitochondrial DNA polymerase γ mutations: an ever expanding molecular and clinical spectrum,” Journal of Medical Genetics, vol. 48, no. 10, pp. 669–681, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Parikh, A. Goldstein, M. K. Koenig et al., “Practice patterns of mitochondrial disease physicians in North America. Part 1: diagnostic and clinical challenges,” Mitochondrion, vol. 14, no. 1, pp. 26–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. J. Dixon-Salazar, J. L. Silhavy, N. Udpa et al., “Exome sequencing can improve diagnosis and alter patient management,” Science Translational Medicine, vol. 4, no. 138, Article ID 138ra78, pp. 138–178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Barboza-Cerda, L. D. Campos-Acevedo, R. Rangel, L. E. Martínez-de-Villarreal, and M. A. Déctor, “A novel phenotype characterized by digital abnormalities, intellectual disability, and short stature in a Mexican family maps to Xp11.4-p11.21,” American Journal of Medical Genetics Part A, vol. 161, no. 2, pp. 237–243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Barboza-Cerda, L.-J. Wong, L. E. Martínez-de-Villarreal, V. W. Zhang, and M. A. Déctor, “A novel EBP c.224T>A mutation supports the existence of a male-specific disorder independent of CDPX2,” The American Journal of Medical Genetics Part A, vol. 164, no. 7, pp. 1642–1647, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Marini, A. Forlino, W. A. Cabral et al., “Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans,” Human Mutation, vol. 28, no. 3, pp. 209–221, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Rainger, D. Pehlivan, S. Johansson et al., “Monoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformations,” The American Journal of Human Genetics, vol. 94, no. 6, pp. 915–923, 2014. View at Publisher · View at Google Scholar
  9. J. de Ligt, P. M. Boone, R. Pfundt et al., “Detection of clinically relevant copy number variants with whole-exome sequencing,” Human Mutation, vol. 34, no. 10, pp. 1439–1448, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. S. Poultney, A. P. Goldberg, E. Drapeau et al., “Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder,” American Journal of Human Genetics, vol. 93, no. 4, pp. 607–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Moreno-De-Luca, S. M. Myers, T. D. Challman, D. Moreno-De-Luca, D. W. Evans, and D. H. Ledbetter, “Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence,” The Lancet Neurology, vol. 12, no. 4, pp. 406–414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Wu, X. Ming, J. Xiao et al., “TBX6 null variants and a common hypomorphic allele in congenital scoliosis,” The New England Journal of Medicine, vol. 372, no. 4, pp. 341–350, 2015. View at Publisher · View at Google Scholar
  13. L. N. Moens, E. Falk-Sörqvist, A. C. Asplund et al., “Diagnostics of primary immunodeficiency diseases: a sequencing capture approach,” PLoS ONE, vol. 9, no. 12, Article ID e114901, 2014. View at Publisher · View at Google Scholar
  14. A. C. Need, V. Shashi, Y. Hitomi et al., “Clinical application of exome sequencing in undiagnosed genetic conditions,” Journal of Medical Genetics, vol. 49, no. 6, pp. 353–361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Waters and P. L. Beales, “Ciliopathies: an expanding disease spectrum,” Pediatric Nephrology, vol. 26, no. 7, pp. 1039–1056, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Badano, C. C. Leitch, S. J. Ansley et al., “Dissection of epistasis in oligogenic Bardet-Biedl syndrome,” Nature, vol. 439, no. 7074, pp. 326–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Bandano, J. C. Kim, B. E. Hoskins et al., “Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Beidl patients with two mutations at a second BBS locus,” Human Molecular Genetics, vol. 12, no. 14, pp. 1651–1659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Marion, F. Stutzmann, M. Gérard et al., “Exome sequencing identifies mutations in LZTFL1, a BBSome and smoothened trafficking regulator, in a family with Bardet-Biedl syndrome with situs inversus and insertional polydactyly,” Journal of Medical Genetics, vol. 49, no. 5, pp. 317–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Rose, A. Z. Shah, G. Venturini, C. Rivolta, G. E. Rose, and S. S. Bhattacharya, “Dominant PRPF31 mutations are hypostatic to a recessive CNOT3 polymorphism in retinitis pigmentosa: a novel phenomenon of ‘linked trans-acting epistasis’,” Annals of Human Genetics, vol. 78, no. 1, pp. 62–71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Weigelt and J. S. Reis-Filho, “Epistatic interactions and drug response,” Journal of Pathology, vol. 232, no. 2, pp. 255–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. B. R. Korf and H. L. Rehm, “New approaches to molecular diagnosis,” The Journal of the American Medical Association, vol. 309, no. 14, pp. 1511–1521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. T. Miller, M. P. Adam, S. Aradhya et al., “Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies,” American Journal of Human Genetics, vol. 86, no. 5, pp. 749–764, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. C. Koboldt, K. M. Steinberg, D. E. Larson, R. K. Wilson, and E. R. Mardis, “The next-generation sequencing revolution and its impact on genomics,” Cell, vol. 155, no. 1, pp. 27–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. L. Beaulieu, J. Majewski, J. Schwartzentruber et al., “FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project,” The American Journal of Human Genetics, vol. 94, no. 6, pp. 809–817, 2014. View at Publisher · View at Google Scholar
  25. T. A. Manolio, R. L. Chisholm, B. Ozenberger et al., “Implementing genomic medicine in the clinic: the future is here,” Genetics in Medicine, vol. 15, no. 4, pp. 258–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Köhler, S. C. Doelken, C. J. Mungall et al., “The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data,” Nucleic Acids Research, vol. 42, no. 1, pp. D966–D974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Wagle, M. F. Berger, M. J. Davis et al., “High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing,” Cancer Discovery, vol. 2, no. 1, pp. 82–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Hansen and P. L. Bedard, “Clinical application of high-throughput genomic technologies for treatment selection in breast cancer,” Breast Cancer Research, vol. 15, no. 5, article R97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. J. G. Bender, A. Verma, and J. D. Schiffman, “Translating genomic discoveries to the clinic in pediatric oncology,” Current Opinion in Pediatrics, vol. 27, no. 1, pp. 34–43, 2015. View at Publisher · View at Google Scholar
  30. M. Kalia, “Biomarkers for personalized oncology: recent advances and future challenges,” Metabolism, vol. 64, no. 3, supplement 1, pp. S16–S21, 2015. View at Publisher · View at Google Scholar
  31. A.-L. Barabási, N. Gulbahce, and J. Loscalzo, “Network medicine: a network-based approach to human disease,” Nature Reviews Genetics, vol. 12, no. 1, pp. 56–68, 2011. View at Publisher · View at Google Scholar · View at Scopus